New Delhi: The Delhi High Court has dismissed Matrix Cellular Services' plea for release of its seized oxygen concentrators, saying it sold "untested" equipment to desperate people at exorbitant prices by making false representations at a time when there was a surge in COVID-19 cases and severe lack of oxygen supply for patients.
Justice Yogesh Khanna, while denying any relief to the company, further said that it had allegedly sold the concentrators at huge profit margins "in contravention of laws, rules and executive orders".
The court also said that the oxygen concentrators being a lifesaving machine was a drug as defined under the Drugs and Cosmetics Act and therefore, "there appears to be no illegality in the act of respondent (police), especially when the State was reeling in acute shortage of drugs, cylinders, concentrators and attendants of patients were running from pillar to post, ready to part with their life savings for its purchase."
Read:Cyclone-hit states transport 536 MT LMO via Oxygen Express
"A conjoint reading of the FIR, invoices and receipts produced by the petitioner (Matrix) along with the fact that the seized oxygen concentrators were allegedly sold at a huge profit margins in contravention of laws, rules and executive orders..
"The facts show the petitioner was engaged in selling untested oxygen concentrators to people desperate for these devices and at an exorbitant prices through false representations, especially, when the State and the whole country saw an unprecedented surge of COVID-19 infections and severe lack of oxygen cylinders and/or concentrators," the court said.
It also said that prima facie the company's act was "in violation of an office memorandum, Ministry of Chemicals and Fertilizers, Government of India, dated June 29, 2020 which had directed the petitioners and others like him, selling oxygen concentrators, to not increase prices of oxygen concentrators by more than 10 per cent of the maximum retail price in a year of the Drugs Pricing Control Order, 2013".